Trial NCT01051011

View at ClinicalTrials.gov 
Org. Study IDs: ZC22565

Last trial update was posted on 2016-11-02

MeSH Interventions

Glucagon-Like Peptide 1 Insulin Glargine Metformin

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2

Other Conditions

Diabetes Mellitus Type 2

Stopping Reasons

high discontinuation rates mainly due to GI tolerability and implementation of risk mitigation plan to address hypersensitivity reactions

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID